drugset / Trial / NCT02768220
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products
RandomizedCrossoverOpen-labelTreatment
Summary
Single-center open-label multiple dose randomized two period cross-over study to examine Advanced Glycation End Product (AGE) levels in human subjects pre and post empagliflozin administration.
Timeline
- Start
- 2017-12-01
- Primary completion
- 2018-08
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | 25 mg | — |
| Subject | Linagliptin | Small molecule | 5 mg | — |